GEORGIANNE PANGALLO: Open Payments
NPI 1558360230 · FRANKLIN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 30 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $104 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| Collegium Pharmaceutical, Inc. | 4 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Alkermes, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Indivior Inc. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
Products named: Jornay PM, REXULTI, CAPLYTA, FANAPT, INGREZZA, ARISTADA, UZEDY, SUBLOCADE.
Industry payments across IN — which companies pay providers there.
